@article{7f510584ca7b4242ac92ede4981d0a6a,
title = "RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells",
keywords = "immunotherapy, vascular targeting, cytotoxic T lymphocytes, alpha(v)beta(3) integrin, RGD peptide, BISPECIFIC ANTIBODY, TUMOR VASCULATURE, MODIFIED PROTEINS, GROWTH, INTEGRINS, PEPTIDES, CANCER, DELIVERY, THERAPY, VACCINE",
author = "{Leegte - Schraa}, Astrid and R.J Kok and S.M. Botter and S Withoff and Meijer, {D.K F} and {de Leij}, Lou and G Molema",
note = "J Article",
year = "2004",
month = nov,
doi = "10.1002/ijc.20413",
language = "English",
volume = "112",
pages = "279 -- 285",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley",
number = "2",
}